SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Jul. 31, 2015

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

CANTEL MEDICAL CORP.

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

	Balance at											Balance
	Beginning								Translation			at End
	of Period		Additions			(Deductions)			Adjustments			of Period
Allowance for doubtful accounts:
Year ended July 31, 2015	$	1,874,000	$	464,000		$	(227,000	)	$	(19,000	)	$	2,092,000
Year ended July 31, 2014	$	1,265,000	$	706,000		$	(95,000	)	$	(2,000	)	$	1,874,000
Year ended July 31, 2013	$	1,041,000	$	516,000		$	(291,000	)	$	(1,000	)	$	1,265,000
Reserve for excess and obsolete inventory:
Year ended July 31, 2015	$	4,419,000	$	1,494,000		$	(1,796,000	)	$	(222,000	)	$	3,895,000
Year ended July 31, 2014	$	1,781,000	$	3,480,000		$	(802,000	)	$	(40,000	)	$	4,419,000
Year ended July 31, 2013	$	1,957,000	$	750,000		$	(922,000	)	$	(4,000	)	$	1,781,000
	.
Deferred tax asset valuation allowance:
Year ended July 31, 2015	$	3,538,000	$	1,010,000		$	(2,420,000	)(1)	$	(91,000	)	$	2,037,000
Year ended July 31, 2014	$	308,000	$	3,363,000	(1)	$	(126,000	)	$	(7,000	)	$	3,538,000
Year ended July 31, 2013	$	1,275,000	$	133,000		$	(1,023,000	)	$	(77,000	)	$	308,000

(1) The amounts primarily include additions and deductions of valuation allowances associated with New Jersey net operating losses, as further explained in Note 10 to the Consolidated Financial Statements.